ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Corning has expanded its life sciences business by acquiring Axygen BioScience from the private equity firm American Capital for about $400 million in cash. With headquarters in Union City, Calif., Axygen produces plastic labware, liquid-handling products, and benchtop lab equipment. “We believe this highly strategic acquisition offers synergies that will allow us to grow our life sciences business to more than $500 million in revenue by 2011,” Corning President Peter F. Volanakis says. Corning already supplies labware, cell culture, and high-throughput- screening products.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter